Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys.
Andreas D HaasElizabeth RadinAvi J HakimAndreas JahnNeena M PhilipSasi JonnalagaddaSuzue SaitoAndrea Jane LowHetal PatelAmee M SchwittersJohn H RogersKoen FrederixEvelyn KimGeorge BelloDaniel B WilliamsBharat ParekhKarampreet SachathepDanielle T BarradasThokozani KaluaSehin BirhanuGodfrey N MusukaOwen MugurungiBeth A Tippett BarrKatrina SleemanLloyd B MulengaKyaw ThinTrong T AoKristin BrownAndrew C VoetschJessica E JustmanPublished in: Journal of the International AIDS Society (2021)
Countries are approaching global VLS targets for adults. Treatment support, in particular for younger adults, and people with higher CD4 counts, and switching of people to protease inhibitor- or integrase inhibitor-based regimens may further reduce NVL prevalence.